We're Open
+44 7340 9595 39
+44 20 3239 6980

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinic

Information



  • Post Date 2020-03-25T13:30:14+00:00
  • Post Category Academic Papers

No Plagiarism Guarantee - 100% Custom Written

Order Details

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models

 

 

Get this assignment Plagiarism-free and Custom-written from Insta Research


Price: £ 99

100% Plagiarism Free & Custom Written, Tailored to your instructions